Fig. 4From: Evaluation of a multi-arm multi-stage Bayesian design for phase II drug selection trials – an example in hemato-oncologyPosterior stopping rules according to the actual treatment benefit and sample size; the left plots refer to decision criterion 1 with p0=0.15, the middle plots refer to criterion 2 with Δ=0, and the right plots refer to criterion 3 with δ*=0.15. The mean estimates are from N=10,000 independent simulations for each actual benefit (dB)Back to article page